Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer - Evaluating radiation, ablation, and surgery (ERASur) Meeting Abstract
| Authors: | Hitchcock, K.; Romesser, P. B.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; Yaeger, R.; Shergill, A.; Hong, T. S.; George, T. J.; O'Reilly, E. M.; Meyerhardt, J. A.; Miller, E. D. |
| Abstract Title: | Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer - Evaluating radiation, ablation, and surgery (ERASur) |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Keywords: | 261-492-3532-2370-7650-2700; 283-237-255; 38092-18849; 283-237-255-11316; 261-566-11347; 261-137-3222-7310; 261-137-3222-3876-5567; 261-7540; 227-12145; 261-7474 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500090 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.TPS236 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS236 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work